This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Delivered as a Hybrid Event
September 27-30, 2022,
Boston Convention and Exhibition Center

The Cell, Gene & Immunotherapy Event for Improving Manufacturing Efficiencies, Costs and Quality

Accelerate your bioprocessing, analytics, supply chain security and commercialization strategies by accessing novel science, technologies and the contacts you need

Cell & Gene US 2022 Full Agenda Released!

Our agenda for Cell & Gene Therapy Manufacturing & Commercialization US features 5 conference tracks in Cell Therapy, Gene Edited Ex Vivo Cell Therapy, In Vivo Gene Therapy, Cell and Gene Therapy – Partnering Track, and New Frontiers for Cell and Tissue Manufacturing: In collaboration with ARMI.   Download our full agenda now and be sure to register early to secure our lowest rates. 

Bringing you cutting edge case studies across the cell, gene & immunotherapy spectrum

Following a year where we have had little to no social interaction or face to face discussions, make sure you join us in Boston to benefit from dedicated content broken down to suit your area of expertise and jam packed with the leading pioneers in the space

Cell Therapy

  • Discover process optimization and implementation strategies for automated, closed, and integrated systems in autologous cell therapy manufacturing
  • Build your analytical toolbox to improve testing, characterization & validation strategies
  • Get to grips with raw materials, cryopreservation, and logistical requirements for seamless end to end supply chains

Gene Edited Ex Vivo Cell Therapy

  • Hear the latest scale up strategies for robust manufacturing of next generation “off the shelf” allogeneic and gene edited modalities
  • Tackle CAR-Ts, NK cells, TCRs, TILs and iPSCs commercialization with manufacturing and patient delivery models at scale
  • Beyond rare diseases: Overcome the challenges of expanding to larger patient populations with cell and gene therapies

In Vivo Gene Therapy

  • Hear case studies on how to increase speed, consistency, scalability, and flexibility in gene therapy manufacturing
  • Develop analytical toolkits for AAV characterization and understanding CQAs
  • Evaluate new technologies to overcome downstream processing and viral clearance challenges

Partnering & Collaborations

  • Get a global view on value, regulatory considerations, pricing, and access for novel therapies 
  • Discover investors views on innovation in the cell and gene therapy space
  • Explore best practices for working with CDMOs and suppliers

Cell and Tissue Manufacturing – in collaboration with ARMI

  • Generate high quality cellular starting materials with access to the latest harvesting and cell culture expansion technologies
  • Hear the latest trends in real-time and online sensors for monitoring cell and tissue attributes during culture, expansion, and maturation
  • Discuss cost-effective process development and robust CMC strategies for designing and obtaining commercial approval for tissue and cell based regenerative medicines

Co-located with the BPI Conference & Expo

  • Benefit from a conference pass including access to all talks and content across both events 
  • Maximize networking opportunities with attendees working in MAbs, vaccines & novel biological products
  • Connect with leading technology innovators across all phases of biopharmaceutical production and development 

PRESENT A SCIENTIFIC POSTER AT Cell & Gene Therapy Manufacturing & Commercialization US 2022 | Due August 26th

Any registered All Access Pass attendee is eligible to register for a scientific poster space at no additional charge. All poster abstracts must be summited by August 26. For full poster specifications and to submit your poster abstract, click the button below.

CONNECT WITH KEY BUYERS AT Cell & Gene Therapy 2022

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: Perri.Lucatello@informa.com | +44 208 052 0465